Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    LSD

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    $ API Ref.Price (USD/KG) : 4,409Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    MindMed Has Productive End-Of-Phase 2 Meeting With FDA For MM120 In GAD
    MindMed Has Productive End-Of-Phase 2 Meeting With FDA For MM120 In GAD

    20 Jun 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240620626324/en

    BUSINESSWIRE
    20 Jun 2024
    Share Share
    BetterLife Files Comprehensive Patent for BETR-001 and Other LSD Derivatives
    BetterLife Files Comprehensive Patent for BETR-001 and Other LSD Derivatives

    27 Sep 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/09/27/2523270/0/en/BetterLife-Files-Comprehensive-Patent-for-BETR-001-and-Other-LSD-Derivatives.html

    GLOBENEWSWIRE
    27 Sep 2022
    Share Share
    MindMed Shows Publication of Study Comparing Acute Effects of LSD and Psilocybin
    MindMed Shows Publication of Study Comparing Acute Effects of LSD and Psilocybin

    02 Mar 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/mindmed-announces-publication-of-study-comparing-the-acute-effects-of-lysergic-acid-diethylamide-and-psilocybin-in-healthy-subjects-301493703.html

    PRNEWSWIRE
    02 Mar 2022
    Share Share
    BetterLife Lead Drug (BETR-001) Promotes Structural Neural Plasticity
    BetterLife Lead Drug (BETR-001) Promotes Structural Neural Plasticity

    15 Feb 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/02/15/2385232/0/en/BetterLife-Lead-Drug-BETR-001-Promotes-Structural-Neural-Plasticity-in-Preclinical-Model.html

    GLOBENEWSWIRE
    15 Feb 2022
    Share Share
    BetterLife Receives FDA Response On Its Pre-IND Application For Major Depressive Disorder (MDD) Treatment With BETR-001
    BetterLife Receives FDA Response On Its Pre-IND Application For Major Depressive Disorder (MDD) Treatment With BETR-001

    20 Jan 2022

    // PRESS RELEASE

    https://www.pharmacompass.com/pdf/news/betterlife-receives-fda-response-on-its-pre-ind-application-for-major-depressive-disorder-mdd-treatment-with-betr-001-1643725774.pdf

    PRESS RELEASE
    20 Jan 2022
    Share Share
    MindMed Initiates Phase 2a LSD Trial for the Treatment of Adult ADHD
    MindMed Initiates Phase 2a LSD Trial for the Treatment of Adult ADHD

    17 Dec 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/mindmed-initiates-phase-2a-lsd-trial-for-the-treatment-of-adult-adhd-301447252.html

    PRNEWSWIRE
    17 Dec 2021
    Share Share